Literature DB >> 18758688

NEFL Pro22Arg mutation in Charcot-Marie-Tooth disease type 1.

Ji Soo Shin1, Ki Wha Chung2, Sun Young Cho1, Jiyoung Yun1, Su Jin Hwang1, Sung Hee Kang2, En Min Cho2, Seung-Min Kim3, Byung-Ok Choi4.   

Abstract

Charcot-Marie-Tooth disease (CMT) is classified into demyelinating neuropathy (CMT1) and axonal neuropathy (CMT2). Mutations in the neurofilament light chain polypeptide (NEFL) gene are present in CMT2E and CMT1F neuropathies. Two types of Pro22 mutations have been previously reported: Pro22Ser in CMT2E with giant axons, and Pro22Thr in CMT1F. In this study, we identified another Pro22 mutation, Pro22Arg, in a Korean CMT1 family. An investigation to identify the clinical and pathological characteristics of the Pro22Arg revealed that it is associated with demyelinating neuropathy features in CMT1F. Histopathological findings showed onion bulb formations but no giant axons. It appears that the Pro22 mutations may influence not only the Thr-Pro phosphorylation site by proline-directed protein kinases but also other structural alteration of the NEFL protein in a different way.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758688     DOI: 10.1007/s10038-008-0333-8

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  12 in total

1.  A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family.

Authors:  Donna-Maria Georgiou; Janez Zidar; Marko Korosec; Lefkos T Middleton; Theodoros Kyriakides; Kyproula Christodoulou
Journal:  Neurogenetics       Date:  2002-10       Impact factor: 2.660

2.  Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants.

Authors:  Takahiro Sasaki; Takahiro Gotow; Motoko Shiozaki; Fumika Sakaue; Taro Saito; Jean-Pierre Julien; Yasuo Uchiyama; Shin-Ichi Hisanaga
Journal:  Hum Mol Genet       Date:  2006-02-01       Impact factor: 6.150

3.  Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport.

Authors:  Raül Pérez-Ollé; Miguel A López-Toledano; Dmitry Goryunov; Noemi Cabrera-Poch; Leonidas Stefanis; Kristy Brown; Ronald K H Liem
Journal:  J Neurochem       Date:  2005-05       Impact factor: 5.372

4.  Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients.

Authors:  Byung-Ok Choi; Mi Sun Lee; Sang Hee Shin; Jung Hee Hwang; Kyoung-Gyu Choi; Won-Ki Kim; Il Nam Sunwoo; Nam Keun Kim; Ki Wha Chung
Journal:  Hum Mutat       Date:  2004-08       Impact factor: 4.878

5.  Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E.

Authors:  G M Fabrizi; T Cavallaro; C Angiari; L Bertolasi; I Cabrini; M Ferrarini; N Rizzuto
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

6.  The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy.

Authors:  Stephan Züchner; Matthias Vorgerd; Eckhart Sindern; J Michael Schröder
Journal:  Neuromuscul Disord       Date:  2004-02       Impact factor: 4.296

7.  Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease.

Authors:  A Jordanova; P De Jonghe; C F Boerkoel; H Takashima; E De Vriendt; C Ceuterick; J-J Martin; I J Butler; P Mancias; S Ch Papasozomenos; D Terespolsky; L Potocki; C W Brown; M Shy; D A Rita; I Tournev; I Kremensky; J R Lupski; V Timmerman
Journal:  Brain       Date:  2003-03       Impact factor: 13.501

8.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

9.  Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton.

Authors:  Gian Maria Fabrizi; Tiziana Cavallaro; Chiara Angiari; Ilaria Cabrini; Federica Taioli; Giovanni Malerba; Laura Bertolasi; Nicoló Rizzuto
Journal:  Brain       Date:  2006-10-18       Impact factor: 13.501

10.  Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport.

Authors:  Janet Brownlees; Steven Ackerley; Andrew J Grierson; Nick J O Jacobsen; Kerry Shea; Brian H Anderton; P Nigel Leigh; Christopher E Shaw; Christopher C J Miller
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

View more
  15 in total

1.  NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.

Authors:  José Berciano; Antonio García; Kristien Peeters; Elena Gallardo; Els De Vriendt; Ana L Pelayo-Negro; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

2.  Toxic PR Poly-Dipeptides Encoded by the C9orf72 Repeat Expansion Target LC Domain Polymers.

Authors:  Yi Lin; Eiichiro Mori; Masato Kato; Siheng Xiang; Leeju Wu; Ilmin Kwon; Steven L McKnight
Journal:  Cell       Date:  2016-10-20       Impact factor: 41.582

3.  NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.

Authors:  José Berciano; Kristien Peeters; Antonio García; Tomás López-Alburquerque; Elena Gallardo; Arantxa Hernández-Fabián; Ana L Pelayo-Negro; Els De Vriendt; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

Review 4.  Dysfunctions of neuronal and glial intermediate filaments in disease.

Authors:  Ronald K H Liem; Albee Messing
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 5.  Charcot-Marie-Tooth disease and intracellular traffic.

Authors:  Cecilia Bucci; Oddmund Bakke; Cinzia Progida
Journal:  Prog Neurobiol       Date:  2012-03-22       Impact factor: 11.685

6.  Genetic and clinical characteristics of NEFL-related Charcot-Marie-Tooth disease.

Authors:  Alejandro Horga; Matilde Laurà; Zane Jaunmuktane; Nivedita U Jerath; Michael A Gonzalez; James M Polke; Roy Poh; Julian C Blake; Yo-Tsen Liu; Sarah Wiethoff; Conceição Bettencourt; Michael Pt Lunn; Hadi Manji; Michael G Hanna; Henry Houlden; Sebastian Brandner; Stephan Züchner; Michael Shy; Mary M Reilly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-05-13       Impact factor: 10.154

Review 7.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

8.  Vimentin phosphorylation and assembly are regulated by the small GTPase Rab7a.

Authors:  Laura Cogli; Cinzia Progida; Roberta Bramato; Cecilia Bucci
Journal:  Biochim Biophys Acta       Date:  2013-02-28

9.  Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.

Authors:  Paul D Leger; Daniel H Johnson; Gregory K Robbins; Robert W Shafer; David B Clifford; Jun Li; Paul J McLaren; David W Haas
Journal:  J Neurovirol       Date:  2014-02-20       Impact factor: 2.643

10.  The first Portuguese family with NEFL-related Charcot-Marie-Tooth type 2 disease.

Authors:  Rita Machado; Jorge Pinto-Basto; Luís Negrão
Journal:  Acta Myol       Date:  2019-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.